G. Mahy

发表

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

David C. Wilson, Judy H. Cho, C. Gieger, 2012, Nature.

IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes

David C. Wilson, Judy H. Cho, C. Gieger, 2018, Nature Communications.

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Judy H. Cho, John P. Ferguson, G. Wainrib, 2019, Scientific Reports.

Genetic Susceptibility in IBD: Overlap Between Ulcerative Colitis and Crohn's Disease

Z. Zhao, G. Montgomery, J. Andrews, 2013, Inflammatory bowel diseases.

A cautionary tale of biologic therapy

G. Mahy, J. Masson, L. P. Chang, 2009, Internal medicine journal.

Higher anti-tumour necrosis factor-α levels correlate with improved radiological outcomes in Crohn's perianal fistulas.

G. Mahy, M. Bastian-Jordan, S. Connor, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford

S. Travis, J. Andrews, P. Bampton, 2020, World journal of gastroenterology.

Crohn's disease and smoking: is it ever too late to quit?

J. Andrews, P. Bampton, R. Gearry, 2013, Journal of Crohn's & colitis.

Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease

G. Mahy, J. Ramage, A. Mahmood, 2005, European journal of gastroenterology & hepatology.

High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

Hailiang Huang, Stephan Ripke, Andre Franke, 2014, Nature Genetics.

Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease

Judy H. Cho, C. Gieger, M. Daly, 2012 .

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Judy H. Cho, John P. Ferguson, G. Wainrib, 2019, Scientific Reports.

Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method

Sang Hong Lee, Peter M Visscher, Naomi R Wray, 2017, BMC Medical Genetics.

An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis

G. Montgomery, J. Andrews, P. Bampton, 2021, bioRxiv.

Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study

J. Andrews, P. Bampton, R. Gearry, 2017, Alimentary pharmacology & therapeutics.

Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma

G. Mahy, K. Sangla, U. Malabu, 2011, Case reports in endocrinology.

BEYOND STATIN THERAPY: NOVEL THERAPEUTIC APPROACHES FOR THE MANAGEMENT OF LOW HIGH‐DENSITY LIPOPROTEIN CHOLESTEROL

G. Mahy, D. Twite, Richard White, 2020 .

Rare case of sclerosing mesenteritis and low grade follicular lymphoma.

G. Mahy, Seema Shah, E. Roche, 2016, World journal of clinical cases.

High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

Judy H. Cho, C. Gieger, H. Hakonarson, 2015 .

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Lisa, Husam, John P. Ferguson, 2023 .

Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study.

J. Andrews, P. Bampton, R. Gearry, 2012, Journal of Crohn's & colitis.